awmsg logo


AWMSG medicines optimisation guidance documents undergo national consultation prior to endorsement and publication. The following documents are currently under consultation and the views of healthcare professionals, industry representatives and patients/patient groups are welcomed. Please complete the associated pro-forma and return to

Please note: Comments received during consultation are compiled in a report and considered by the development group. Each comment will be addressed and any changes to the document that are made as a result will be noted. The summary report including any comments submitted will be available upon request.

AWTTC reserves the right to summarise comments, where it is deemed appropriate, and to not publish comments if we consider their publication to be unlawful or otherwise inappropriate.

By submitting your comments, you are agreeing to them being used in line with the above.

To request a consultation comment summary, please contact: Please allow three weeks from the close of the consultation period for the summary to be available.


Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile

The Adverse Drug Reaction (ADRe) Profile for mental health medicines, developed by Swansea University with input from other institutions, is an innovative, comprehensive approach to unifying the input of all healthcare professionals with the service user’s experiences. It aims to ensure that problems arising from service users’ mental health medicines are recognised and addressed, admissions are prevented, doses of antipsychotics and sedatives are reduced, service users’ well-being is improved, and all professionals and service users input into prescribing decisions, particularly repeat prescribing.

Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile - Consultation draft
Mental Health Medicines in Older Adults - the Adverse Drug Reaction (ADRe) Profile - Consultation pro-forma

Consultation closes: 28 November 2018

National Prescribing Indicators 2019-2020

Prescribing indicators are used to highlight therapeutic priorities for NHS Wales and compare the ways in which different prescribers and organisations use particular medicines or groups of medicines. Each of the NPIs for 2019–2020 has a focus on safety, stewardship or efficiency.

National Prescribing Indicators 2019-2020 - Consultation document
National Prescribing Indicators 2019-2020 - Consultation pro-forma

Consultation closes: 23 November 2018